Degnan Chris
SEC CIK 1741968 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | CFO | 4,483 | — | $37.1K | 2 | 2025-10-08 | 2025-10-08 |
Most active insiders at URGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schoenberg Mark | Chief Medical Off | — | $4.48M |
| 2 | Smith Jason Drew | GC | — | $211.9K |
| 3 | Degnan Chris | CFO | — | $37.1K |
| 4 | Wildman Daniel George | Dir | — | — |
| 5 | WEN LEANA | Dir | — | — |
| 6 | Holden Stuart | Dir | — | — |
| 7 | Robinson James A. Jr. | Dir | — | — |
| 8 | BUTITTA CYNTHIA M | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-09 | 2025-10-08 | URGN | UroGen Pharma Ltd. | Degnan Chris | CFO | M - OptEx | — | +4,483 | 4,483 | New | — |
| D | 2025-10-09 | 2025-10-08 | URGN | UroGen Pharma Ltd. | Degnan Chris | CFO | S - Sale+OE | $16.85 | -2,203 | 2,280 | -49% | -$37.1K |
Purchase Sale Sale after option exercise All abbreviations